Vance Street merges three medical device makers into one manufacturer
What's the deal? MRPCDealroom has a profile for this one. Try Dealroom →, Plastic Design Company (PDC)Dealroom has a profile for this one. Try Dealroom →, and InjectechDealroom has a profile for this one. Try Dealroom → have merged into a single medical device manufacturer, uniting precision molding, cleanroom assembly, and fluid management components under one organization. The three companies, each acquired by private equity firm Vance Street CapitalDealroom has a profile for this one. Try Dealroom → between 2021 and 2025, are now operating as one. Deal terms were undisclosed.
What's the endgame? The combined company aims to be a single-source supplier for the medical device, life science, and bioprocessing markets. It offers silicone and thermoplastic molding, micro injection molding, cleanroom assembly, packaging, and sterilization management, plus a catalog of fluid management components.
Why now? Medical device companies often coordinate several specialized manufacturers to advance one complex program. "This combination gives them a clearer path to the expertise they need across components, assemblies, and finished devices," said Steve Sandbo, partner at Vance Street Capital and chairman of the combined company's board.
Greg Riemer, chief executive officer of MRPC, will lead the merged organization as CEO. He became president of MRPC in 2010 and has more than three decades in plastic, silicone, and rubber molding.
What's next? The three brands will exhibit together for the first time at MD&M Midwest, October 28 to 29, 2026, at the Minneapolis Convention Center. A unified brand identity is planned for early 2027.
The signal: The merger reflects consolidation in medical manufacturing, where customers increasingly seek fewer suppliers capable of handling a program from component to finished device. "Highly engineered medical manufacturing rewards depth," Riemer said.
Read more: plasticstoday.com
Image credit: Generated with Gemini
